KYNU and neoplasm: These dual impacts—on RNS generation and NAD metabolism—highlight kynureninase’s potential as a critical regulator of immune evasion in LUAD and underscore the therapeutic promise of targeting KYNU to restore immune function in the tumor microenvironment.